{
    "nct_id": "NCT03850483",
    "official_title": "A PHASE 2B, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED, PARALLEL-GROUP, DOSE RANGING STUDY TO ASSESS EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06700841 TOPICAL CREAM APPLIED ONCE OR TWICE DAILY FOR 12 WEEKS IN PARTICIPANTS WITH MILD TO MODERATE CHRONIC PLAQUE PSORIASIS",
    "inclusion_criteria": "* plaque psoriasis for 6 months\n* PGA score mild or moderate\n* body surface area (BSA) 2-15%\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* other skin conditions that would interfere with the evaluation of psoriasis\n* history of herpes zoster or simplex\n* Infected with Mycobacterium tuberculosis",
    "miscellaneous_criteria": ""
}